A new therapeutic avenue for the treatment of Alzheimer's
( a radically different approach )
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
If you can't stop the beta-amyloid protein plaques from forming in Alzheimer's disease patients, then maybe you can help the body rid itself of them instead. At least that's what scientists from New York were hoping for when they found a drug candidate to do just that. Their work appears in a research report online in The FASEB Journal (http://www.fasebj.org), and shows that a new compound, called "SMER28" stimulated autophagy in rat and mice cells.
Autophagy is a process cells use to "clean out" the debris from their interior, including unwanted materials such as the protein aggregates that are hallmarks of Alzheimer's disease. In mice and rat cells, SMER28 effectively slowed down the accumulation of beta-amyloid.
"Our work demonstrates that small molecules can be developed as therapies, by activating a cellular function called autophagy, to prevent Alzheimer's disease," said Paul Greengard, Ph.D.,Nobel laureate and director of the Laboratory of Molecular and Cellular Neuroscience at The Rockefeller University in New York, NY. "By increasing our understanding of autophagy, it might be possible to stimulate it pharmacologically or naturally to improve the quality of life for aging people." Read more: innovations-report.com
The nutrition of cognition
Supplementation with docosahexaenoic acid (DHA), uridine, and choline may improve the cognitive functions of Alzheimer’s patients, according to a new review. Read more: nutraingredients.com
No comments:
Post a Comment